Robert C. King

发表

Erratum to “Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET”[Nucl. Med. Biol. 2010;37:565–575]

Veerle Kersemans, Catherine Kelly, Laurence Carroll, 2010 .

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

M. Ocak, S. Mather, C. Decristoforo, 2009, Journal of medicinal chemistry.

99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo

C. Finucane, S. Mather, P. Blower, 2009, Journal of Nuclear Medicine.

Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.

S. Mather, P. Blower, R. King, 2009, Journal of inorganic biochemistry.

How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies.

S. Mather, P. Blower, R. King, 2007, Dalton transactions.

In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)–Glucose Conjugate for Hypoxia Imaging

F. Aigbirhio, J. Dilworth, J. Holland, 2008, Journal of Nuclear Medicine.

Orthogonal 18F and 64Cu labelling of functionalised bis(thiosemicarbazonato) complexes.

J. Declerck, A. Gee, L. Carroll, 2010, Chemical communications.

In Vitro and In Vivo Evaluations of a Hydrophilic 64Cu-Bis(Thiosemicarbazonato)–Glucose Conjugate for Hypoxia Imaging

F. Aigbirhio, J. Dilworth, J. Holland, 2008, Journal of Nuclear Medicine.

Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.

Veerle Kersemans, Sean Smart, Arkadij M Elizarov, 2010, Nuclear medicine and biology.